Delivering the power of discovery in large pharmaceutical organizations
Related Experiment Video
Updated: Sep 21, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Tim Peakman1, Steven Franks, Colm White
1IBM Business Consulting Services, Harman House, 1 George Street, Uxbridge, Middlesex UB8 1QQ, UK. tim.c.peakman@uk.ibm.com
Abstract:
Increasing the output from discovery is currently a major objective for the pharmaceutical industry aimed at reversing recent downward trends in productivity. Although significant attention has been focused on innovative assay and process technologies, these only address specific points in the discovery process. Little effort has been made to manage the multiple interconnected steps within discovery effectively. This manifests itself in low utilization rates of component elements and low expectations of delivery to any agreed timescale.
Related Concept Videos
Drug Discovery: Overview
Clinical Trials: Overview
Preclinical Development: Overview
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Biopharmaceutics and Pharmacokinetics: Overview
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

